Symptoms at disease onset predict prognosis in COVID-19 disease.

IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Aiyuan Zhou, Qing Song, Yating Peng, Xin Liao, Peng Huang, Wenlong Liu, Zhi Xiang, Qimi Liu, Mingyan Jiang, Xudong Xiang, Dingding Deng, Ping Chen
{"title":"Symptoms at disease onset predict prognosis in COVID-19 disease.","authors":"Aiyuan Zhou,&nbsp;Qing Song,&nbsp;Yating Peng,&nbsp;Xin Liao,&nbsp;Peng Huang,&nbsp;Wenlong Liu,&nbsp;Zhi Xiang,&nbsp;Qimi Liu,&nbsp;Mingyan Jiang,&nbsp;Xudong Xiang,&nbsp;Dingding Deng,&nbsp;Ping Chen","doi":"10.1080/19932820.2021.2010338","DOIUrl":null,"url":null,"abstract":"<p><p>The main clinical manifestations of coronavirus disease 2019 (COVID-19) onset are respiratory symptoms, including cough, sputum, and dyspnea. However, a significant proportion of patients initially manifested non-respiratory symptoms, such as fever, myalgia, and diarrhea. Here, we compared the different characteristics and outcomes between the patients with respiratory symptoms and non-respiratory symptoms at illness onset. The patients admitted to the respiratory departments from eight hospitals in Hunan and Guangxi Province with nucleic acid-positive severe acute respiratory syndrome coronavirus (SARS-CoV-2) were recruited. Epidemiological information, clinical manifestations, laboratory findings, and radiological characteristics, treatment regimens, and outcomes data were recorded and analyzed. The median age of the recruited 541 subjects was 43 years (IQR, 33-55). Of the 541 subjects, 404 (74.5%) subjects had initial symptom that were respiratory, while 137 (25.5%) subjects had non-respiratory symptoms. Respiratory COVID-19 subjects had more secondary bacterial infections (8.7% vs 0.0%, <i>P</i> < 0.001), needed the intensive care unit more (9.7% vs 2.2%, <i>P</i> = 0.005), non-invasive ventilation more (7.2% vs 1.5%, <i>P</i> = 0.004), developed ARDS more (11.4% vs 2.2%, <i>P</i> = 0.001) and needed longer time to recover (18.5 vs 16.7 days, <i>P</i> = 0.003) compared to predominately non-respiratory COVID-19 subjects. The multivariate model showed that age (OR = 1.04, <i>P</i> = 0.01), dyspnea (OR = 4.91, <i>P</i> < 0.001) and secondary bacterial infection (OR = 19.8, <i>P</i> < 0.001) were independently associated with development of ARDS among COVID-19 patients. We identify COVID-19 subjects with dyspnea at disease onset who have a worse prognosis. We also demonstrate age and secondary bacterial infections to be independently associated with ARDS development in subjects with COVID-19.<b>ABBREVIATIONS</b>: COVID-19: Coronavirus disease 2019; ARDS: acute respiratory distress syndrome; IQR: interquartile range; ICU: intensive care unit; CDC: Chinese Center for Disease Control and Prevention.</p>","PeriodicalId":49910,"journal":{"name":"Libyan Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/92/ZLJM_17_2010338.PMC8725726.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Libyan Journal of Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/19932820.2021.2010338","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 5

Abstract

The main clinical manifestations of coronavirus disease 2019 (COVID-19) onset are respiratory symptoms, including cough, sputum, and dyspnea. However, a significant proportion of patients initially manifested non-respiratory symptoms, such as fever, myalgia, and diarrhea. Here, we compared the different characteristics and outcomes between the patients with respiratory symptoms and non-respiratory symptoms at illness onset. The patients admitted to the respiratory departments from eight hospitals in Hunan and Guangxi Province with nucleic acid-positive severe acute respiratory syndrome coronavirus (SARS-CoV-2) were recruited. Epidemiological information, clinical manifestations, laboratory findings, and radiological characteristics, treatment regimens, and outcomes data were recorded and analyzed. The median age of the recruited 541 subjects was 43 years (IQR, 33-55). Of the 541 subjects, 404 (74.5%) subjects had initial symptom that were respiratory, while 137 (25.5%) subjects had non-respiratory symptoms. Respiratory COVID-19 subjects had more secondary bacterial infections (8.7% vs 0.0%, P < 0.001), needed the intensive care unit more (9.7% vs 2.2%, P = 0.005), non-invasive ventilation more (7.2% vs 1.5%, P = 0.004), developed ARDS more (11.4% vs 2.2%, P = 0.001) and needed longer time to recover (18.5 vs 16.7 days, P = 0.003) compared to predominately non-respiratory COVID-19 subjects. The multivariate model showed that age (OR = 1.04, P = 0.01), dyspnea (OR = 4.91, P < 0.001) and secondary bacterial infection (OR = 19.8, P < 0.001) were independently associated with development of ARDS among COVID-19 patients. We identify COVID-19 subjects with dyspnea at disease onset who have a worse prognosis. We also demonstrate age and secondary bacterial infections to be independently associated with ARDS development in subjects with COVID-19.ABBREVIATIONS: COVID-19: Coronavirus disease 2019; ARDS: acute respiratory distress syndrome; IQR: interquartile range; ICU: intensive care unit; CDC: Chinese Center for Disease Control and Prevention.

疾病发病时的症状可预测COVID-19疾病的预后。
2019冠状病毒病(COVID-19)发病的主要临床表现为呼吸道症状,包括咳嗽、痰、呼吸困难。然而,相当比例的患者最初表现为非呼吸道症状,如发烧、肌痛和腹泻。在这里,我们比较了发病时出现呼吸道症状和非呼吸道症状的患者的不同特征和结局。选取湖南、广西两省8家医院收治的冠状病毒(SARS-CoV-2)核酸阳性患者为研究对象。记录和分析流行病学信息、临床表现、实验室结果、放射学特征、治疗方案和结局资料。招募的541名受试者的中位年龄为43岁(IQR, 33-55岁)。在541名受试者中,404名(74.5%)受试者有呼吸道症状,137名(25.5%)受试者有非呼吸道症状。呼吸道COVID-19患者继发细菌感染较多(8.7% vs 0.0%, P = 0.005),无创通气较多(7.2% vs 1.5%, P = 0.004), ARDS发病较多(11.4% vs 2.2%, P = 0.001),恢复时间较长(18.5 vs 16.7天,P = 0.003)。多因素模型显示,年龄(OR = 1.04, P = 0.01)、呼吸困难(OR = 4.91, P PARDS:急性呼吸窘迫综合征;IQR:四分位间距;ICU:重症监护病房;中国疾病预防控制中心。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Libyan Journal of Medicine
Libyan Journal of Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
3.50
自引率
4.20%
发文量
20
审稿时长
>12 weeks
期刊介绍: Libyan Journal of Medicine (LJM) is a peer-reviewed, Open Access, international medical journal aiming to promote heath and health education by publishing high-quality medical research in the different disciplines of medicine. LJM was founded in 2006 by a group of enthusiastic Libyan medical scientists who looked at the contribution of Libyan publications to the international medical literature and saw that a publication outlet was missing. To fill this gap they launched LJM as a tool for transferring current medical knowledge to and from colleagues in developing countries, particularly African countries, as well as internationally.The journal is still led by a group of Libyan physicians inside and outside Libya, but it also enjoys support and recognition from the international medical community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信